We found that cells from FBC patients were significantly more sensitive than controls to this drug (Fig 5B), suggesting that there are deficits in adhesion properties in FBC patient cells and indicating a role of FAK‐related signaling and the actin cytoskeleton in FBC development. This evidence concerns the gene PTK2 and complete blood cell count.